FTSE 100 got a lift as a first treatment for COVID-19, remdesivir, was approved in the US. London’s leading index added 41 points to 5,826 in early dealings.
Gilead Inc (NASDAQ:GILD) produces remdesivir and it is said to cut COVID-19 recovery times by five days. According to the World Health Organisation, though, it has little to no effect in reducing deaths.
UK retail sales volumes rose by 1.5% in September from August’s level. It was the fifth consecutive month of retail sales growth and above February’s pre-pandemic figures.
Remote Monitored Systems, which has agreed to buy P2F, also got a boost. Aminex PLC (LON:AEX) has completed its farm-out deal with ARA Petroleum Tanzania Limited (APT). The company now retains a 25% interest in the Ruvuma asset – which includes the Ntorya gas project and exploration areas – and APT will fund a forward programme.
Shanta Gold Limited (LON:SHG) is to raise a meaty £31mln by way of a placing and a direct subscription of shares priced at a modestly discounted 16.5p each. Directors of the gold miner are stumping up about £270,000.